Evan Schnell
InvestorVenture Partner at Kaleida Capital
About
Evan Schnell is a Venture Partner at Kaleida Capital with over 25 years building and commercializing clinical-grade software across brain-computer interfaces, neuromodulation, and healthcare infrastructure. He is currently Director of Medical Device Software at Axoft and was previously Senior Director of Software at Synchron, and earlier a Principal Software Engineer at Medtronic contributing to the Percept DBS system, with prior roles at McKesson and RelayHealth. He holds an MBA from the University of Minnesota Carlson School of Management and advises Kaleida on NeuroAI, BCI, and regulated digital health.
Invests in
AI & Machine LearningDigital HealthHealthtechMedical Devices
Colleagues at Kaleida Capital
Ariane Tom
Managing Director at Kaleida Capital
Dr. Ariane Tom
Investor at Kaleida Capital
Edward Wood
Scientific Advisory Council at Kaleida Capital
Justin Trotter
Scientific Advisory Council at Kaleida Capital
Kevin Carlberg
Venture Partner at Kaleida Capital
Matt Angle
Scientific Advisory Council at Kaleida Capital
Max Hodak
Scientific Advisory Council at Kaleida Capital
Philip Sabes
Scientific Advisory Council at Kaleida Capital